Dihematoporphyrin Ether. Trioxsalen. Antineoplastic Agents. Dermatologic Agents. Photosensitizing Agents. To Top. *For Patients ...
Dihematoporphyrin Ether. Trioxsalen. Antineoplastic Agents, Alkylating. Alkylating Agents. Molecular Mechanisms of ...
DHP Ether. *Dihematoporphyrin ether. *MalaCards. *Medline Plus. 87806-31-3. *1531856. *7661580 ...
Dihematoporphyrin Ether. The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric ... A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER. ...
Dihematoporphyrin Ether (Porfimer Sodium) 4. protoporphyrin IX 5. chlorin e6 6. Chlorophyll ...
... and dihematoporphyrin ethers. (See, e.g., "Porphyrin Photosensitization", Kessel, D., et al, eds. (1983) Plenum Press.) ... The ether-linked dimer can be formed as a side product in this reaction by substituting alternative acids such as sulfuric acid ... For formation of compounds of the invention where -L- is of the formula ##STR11## i.e., an ether linkage, the Gp vinyl group is ... Linkage between the Gp moiety through the position of R4 to an additional tetrapyrrole-type ring system may be through an ether ...
Mullooly VM, Abramson AL, Shikowitz MJ (1990) Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients ...
Dihematoporphyrin Ether. Phase 2. 47. Angiogenesis Modulating Agents. Phase 2. 48. Vitamins. Phase 2. ...
Examples include dihematoporphyrin ether (DHE), Merocyanine 540 (MC540) and methylene blue.. In any event, an effective ...
5. The composition of claim 4 wherein the concentration of dihematoporphyrin ether is from about 0.5% to about 1.5% by weight. ... The method of claim 29 wherein the concentration of dihematoporphyrin ether in said composition is from about 0.5% to about 5% ... 3. The composition of claim 2 wherein the concentration of dihematoporphyrin ether is from about 0.1% to about 10% by weight. ... 4. The composition of claim 3 wherein the concentration of dihematoporphyrin ether is from about 0.5% to about 5% by weight. ...
TY - JOUR. T1 - Endoprevention of esophageal cancer. T2 - Endoscopic ablation of Barretts metaplasia and dysplasia. AU - Wolfsen, Herbert C.. PY - 2005/11. Y1 - 2005/11. N2 - This review describes the use of endoscopic therapy for the treatment of Barretts disease and the prevention of esophageal carcinoma, predominantly a disease of older white men. While the term endoprevention may be novel, gastroenterologists have been using endoscopic techniques to prevent colon cancer for decades. For the endoprevention of Barretts carcinoma, the regulatory approval for the use of porfimer sodium photodynamic therapy was an important milestone, as this treatment has been proven to safely ablate Barretts glandular epithelium, including high-grade dysplasia, and significantly decrease the risk for the development of invasive cancer in several single-center studies, a prospective multicenter randomized controlled study using expert centralized histopathology analysis and long-term single-center results. ...
In vivo canine coronary artery laser irradiation: photodynamic therapy using dihematoporphyrin ether and 632 nm laser. A safety ...
1.5 to 3.0 mg/kg dihematoporphyrin ethers intravenously administered 48 to 72 hours before laparotomy, 630 nm light was ... Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia. ... Later on it was shown that the most active components of the HpD mixture were dihematoporphyrin esters (DHE). This purified ...
... dihematoporphyrin ether MeSH D03.549.909.500.620 --- mesoporphyrins MeSH D03.549.909.500.640 --- metalloporphyrins MeSH D03.549 ... dihematoporphyrin ether MeSH D03.383.129.578.840.500.620 --- mesoporphyrins MeSH D03.383.129.578.840.500.640 --- ...
... dihematoporphyrin ether - dimesna - dimethyl sulfoxide - dimethylxanthenone acetic acid - diphosphonate - dipyridamole - ...
Dihematoporphyrin Ether. Female. Humans. Male. Neoplasm Staging. Retrospective Studies. Treatment Outcome. *MedlinePlus Health ...
Dihematoporphyrin Ether / administration & dosage. Disability Evaluation. Female. Humans. Male. Neoplasm Staging. Porphyrins / ... Chemical-registry-number] 0 / Porphyrins; 0 / polyhaematoporphyrin; 97067-70-4 / Dihematoporphyrin Ether ...
... "dihematoporphyrin ether". Such porphyrins tend to accumulate semi-preferentially in malignant tissues, but they also accumulate ...
... dihematoporphyrin ether/ester (DHE) because of photobleaching, have been investigated in solutions in vitro. The most promising ... The biological activity of a series of porphyrin dimers and trimers with ester and ether linkages, related to Photofrin II and ...
George, L. A., Sullivan, S. K., Giermasz, A., Rasko, J. E. J., Samelson-Jones, B. J., Ducore, J. M., Cuker, A., Sullivan, L. M., Majumdar, S., Teitel, J., McGuinn, C. E., Ragni, M. V., Luk, A. Y., Hui, D., Wright, J. F., Chen, Y., Liu, Y., Wachtel, K., Winters, A., Tiefenbacher, S. & 8 others, Arruda, V. R., Van Der Loo, J. C. M., Zelenaia, O., Takefman, D., Carr, M. E., Couto, L. B., Anguela, X. M. & High, K. A., Dec 7 2017, In : New England Journal of Medicine. 377, 23, p. 2215-2227 13 p.. Research output: Contribution to journal › Article ...
Dihematoporphyrin Ether Biomarkers of Peripheral Arterial Disease. Kullo, I. J.. National Institutes of Health ...
Dihematoporphyrin Ether Medicine & Life Sciences Squamous Cell Carcinoma Medicine & Life Sciences Hematoporphyrins Medicine & ...
... diethylstilbestrol diphosphate dihematoporphyrin ethers dihydro-5-azacitidine (azacitidine or DHAC) DIMOPP (dose-intensified ... dihematoporphyrin ether dhe = dihydroergotamine dhea = dehydroepiandrosterone dheas = dehydroepiandrosterone sulfate dhf = ... ethylene glycol monohexyl ether egl = eosinophilic granuloma of lung egta = ethylene glycol tetraacetic acid eh = essential ... dipropylene glycol monomethyl ether dph = diaphragm dph = diphenylhydantoin dpi = dietary protein intake dpi = diphenylene ...
Dihematoporphyrin Ether. 24. + 9. Receptor, Platelet-Derived Growth Factor alpha. 24. + 10. Benzamides. 23. + ...
Morgan, R. J., Newman, E. M., Doroshow, J. H., McGonigle, K., Margolin, K., Raschko, J., Chow, W., Somlo, G., Leong, L., Tetef, M., Shibata, S., Hamasaki, V., Carroll, M., Vasilev, S., Akman, S., Coluzzi, P., Wagman, L., Longmate, J., Paz, B., Yen, Y. & 1 others, Klevecz, R., Jul 1 1998, In : Cancer Research. 58, 13, p. 2793-2800 8 p.. Research output: Contribution to journal › Article ...